肺部区域性通气变化:利用超极化气体MR成像的治疗反应映射作为定量生物标志物
本研究对20例成人哮喘患者在吸入沙丁胺醇400 μg前后行超极化氦3通气MR成像,通过治疗反应映射计算区域性气体分布变化(ΔRnet),并与肺功能及%VV比较;ΔRnet与FEV1变化(r=0.70)、FVC变化(r=0.84)和%VV(r=0.56)显著相关,且受试者间变异系数(64%)低于其他指标(≥99%)。
要点
- 超极化氦3通气MR成像的治疗反应映射可定量显示吸入支气管扩张剂后区域性通气变化。
- ΔRnet与FEV1变化(r=0.70)、FVC变化(r=0.84)及%VV(r=0.56)显著相关(P < .01)。
- ΔRnet受试者间变异系数64%,低于其他所有检测指标(≥99%)。
核心结论
- 治疗反应映射可提供关于吸入气体通气对治疗反应的区域性定量信息,该方法可能作为新型呼吸干预的敏感区域性结局指标。
研究设计与样本
- 经国家研究伦理委员会批准并获知情同意的研究,纳入20例成人哮喘患者,使用超极化氦3通气MR成像,在吸入沙丁胺醇400 μg前采集两组基线图像、吸入后采集一组图像,所有图像配准后进行体素比较。
关键影像表现/征象
- 以基线图像变异性确定体素激活阈值并应用于ΔR(r)图,计算汇总的全局治疗反应图ΔRnet。
- ΔRnet与FEV1变化(r=0.70)、FVC变化(r=0.84)及%VV(r=0.56)显著相关(P < .01)。
- 所有指标均检测到显著的正性治疗效应(P < .01)。
诊断标准与关键数值
- 区域治疗反应ΔR(r)计算为干预前后区域气体分布R(r)的差值,R(r)为吸入气体与体素总体积之比并按肺充气容积归一化。
- ΔRnet与FEV1变化的相关系数r=0.70,与FVC变化的r=0.84,与%VV的r=0.56(均P < .01)。
- ΔRnet受试者间变异系数为64%,其他所有检测指标的变异系数≥99%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the magnitude of regional response to respiratory therapeutic agents in the lungs by using treatment response mapping (TRM) with hyperpolarized gas magnetic resonance (MR) imaging. TRM was used to quantify regional physiologic response in adults with asthma who underwent a bronchodilator challenge. Materials and Methods This study was approved by the national research ethics committee and was performed with informed consent. Imaging was performed in 20 adult patients with asthma by using hyperpolarized helium 3 (3He) ventilation MR imaging. Two sets of baseline images were acquired before inhalation of a bronchodilating agent (salbutamol 400 μg), and one set was acquired after. All images were registered for voxelwise comparison. Regional treatment response, ΔR(r), was calculated as the difference in regional gas distribution (R[r] = ratio of inhaled gas to total volume of a voxel when normalized for lung inflation volume) before and after intervention. A voxelwise activation threshold from the variability of the baseline images was applied to ΔR(r) maps. The summed global treatment response map (ΔRnet) was then used as a global lung index for comparison with metrics of bronchodilator response measured by using spirometry and the global imaging metric percentage ventilated volume (%VV). Results ΔRnet showed significant correlation (P < .01) with changes in forced expiratory volume in 1 second (r = 0.70), forced vital capacity (r = 0.84), and %VV (r = 0.56). A significant (P < .01) positive treatment effect was detected with all metrics; however, ΔRnet showed a lower intersubject coefficient of variation (64%) than all of the other tests (coefficient of variation, ≥99%). Conclusion TRM provides regional quantitative information on changes in inhaled gas ventilation in response to therapy. This method could be used as a sensitive regional outcome metric for novel respiratory interventions. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Horn FC, Marshall H, Collier GJ, et al. Regional Ventilation Changes in the Lung: Treatment Response Mapping by Using Hyperpolarized Gas MR Imaging as a Quantitative Biomarker. Radiology. 2017. PMID: 28471738. doi:10.1148/radiol.2017160532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。